177 related articles for article (PubMed ID: 9868173)
1. Phenotypic consequences of a nonsense mutation in the leptin receptor gene (fak) in obese spontaneously hypertensive Koletsky rats (SHROB).
Ishizuka T; Ernsberger P; Liu S; Bedol D; Lehman TM; Koletsky RJ; Friedman JE
J Nutr; 1998 Dec; 128(12):2299-306. PubMed ID: 9868173
[TBL] [Abstract][Full Text] [Related]
2. Reduced insulin receptor signaling in the obese spontaneously hypertensive Koletsky rat.
Friedman JE; Ishizuka T; Liu S; Farrell CJ; Bedol D; Koletsky RJ; Kaung HL; Ernsberger P
Am J Physiol; 1997 Nov; 273(5):E1014-23. PubMed ID: 9374689
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathology in the obese spontaneous hypertensive Koletsky rat: a model of syndrome X.
Ernsberger P; Koletsky RJ; Friedman JE
Ann N Y Acad Sci; 1999 Nov; 892():272-88. PubMed ID: 10842668
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of antihyperglycemic effects of moxonidine in the obese spontaneously hypertensive Koletsky rat (SHROB).
Ernsberger P; Ishizuka T; Liu S; Farrell CJ; Bedol D; Koletsky RJ; Friedman JE
J Pharmacol Exp Ther; 1999 Jan; 288(1):139-47. PubMed ID: 9862764
[TBL] [Abstract][Full Text] [Related]
5. Phenotype of the obese Koletsky (f) rat due to Tyr763Stop mutation in the extracellular domain of the leptin receptor (Lepr): evidence for deficient plasma-to-CSF transport of leptin in both the Zucker and Koletsky obese rat.
Wu-Peng XS; Chua SC; Okada N; Liu SM; Nicolson M; Leibel RL
Diabetes; 1997 Mar; 46(3):513-8. PubMed ID: 9032111
[TBL] [Abstract][Full Text] [Related]
6. Lipidized prolactin-releasing peptide improved glucose tolerance in metabolic syndrome: Koletsky and spontaneously hypertensive rat study.
Mikulášková B; Holubová M; Pražienková V; Zemenová J; Hrubá L; Haluzík M; Železná B; Kuneš J; Maletínská L
Nutr Diabetes; 2018 Jan; 8(1):5. PubMed ID: 29339795
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of obese (ob) gene expression and leptin secretion in obese spontaneously hypertensive rats (obese SHR or Koletsky rats).
Hiraoka J; Hosoda K; Ogawa Y; Ikeda K; Nara Y; Masuzaki H; Takaya K; Nakagawa K; Mashimo T; Sawamura M; Koletsky RJ; Yamori Y; Nakao K
Biochem Biophys Res Commun; 1997 Feb; 231(3):582-5. PubMed ID: 9070850
[TBL] [Abstract][Full Text] [Related]
8. Anti-hyperglycemic activity of moxonidine: metabolic and molecular effects in obese spontaneously hypertensive rats.
Friedman JE; Ishizuka T; Liu S; Farrell CJ; Koletsky RJ; Bedol D; Ernsberger P
Blood Press Suppl; 1998; 3():32-9. PubMed ID: 10321453
[TBL] [Abstract][Full Text] [Related]
9. Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat.
Takaya K; Ogawa Y; Hiraoka J; Hosoda K; Yamori Y; Nakao K; Koletsky RJ
Nat Genet; 1996 Oct; 14(2):130-1. PubMed ID: 8841178
[No Abstract] [Full Text] [Related]
10. Plasma glucagon and free fatty acid responses to a glucose load in the obese spontaneous hypertensive rat (SHROB) model of metabolic syndrome X.
Velliquette RA; Koletsky RJ; Ernsberger P
Exp Biol Med (Maywood); 2002 Mar; 227(3):164-70. PubMed ID: 11856814
[TBL] [Abstract][Full Text] [Related]
11. Targets of protein carbonylation in spontaneously hypertensive obese Koletsky rats and healthy Wistar counterparts: a potential role on metabolic disorders.
Méndez L; Pazos M; Giralt M; Nogués MR; Pérez-Jiménez J; Torres JL; Gallardo JM; Medina I
J Proteomics; 2014 Jun; 106():246-59. PubMed ID: 24793432
[TBL] [Abstract][Full Text] [Related]
12. Sympathoadrenergic suppression improves heart function by upregulating the ratio of sRAGE/RAGE in hypertension with metabolic syndrome.
Selejan SR; Linz D; Tatu AM; Hohl M; Speer T; Ewen S; Mahfoud F; Kindermann I; Zamyatkin O; Kazakov A; Laufs U; Böhm M
J Mol Cell Cardiol; 2018 Sep; 122():34-46. PubMed ID: 30096408
[TBL] [Abstract][Full Text] [Related]
13. Marked insulin resistance in obese spontaneously hypertensive rat adipocytes is ameliorated by in vivo but not in vitro treatment with moxonidine.
Sun Z; Ernsberger P
J Pharmacol Exp Ther; 2007 Feb; 320(2):845-52. PubMed ID: 17095615
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic actions of an insulin receptor activator and a novel peroxisome proliferator-activated receptor gamma agonist in the spontaneously hypertensive obese rat model of metabolic syndrome X.
Velliquette RA; Friedman JE; Shao J; Zhang BB; Ernsberger P
J Pharmacol Exp Ther; 2005 Jul; 314(1):422-30. PubMed ID: 15833894
[TBL] [Abstract][Full Text] [Related]
15. Effects of leptin receptor mutation on Agrp gene expression in fed and fasted lean and obese (LA/N-faf) rats.
Korner J; Wardlaw SL; Liu SM; Conwell IM; Leibel RL; Chua SC
Endocrinology; 2000 Jul; 141(7):2465-71. PubMed ID: 10875247
[TBL] [Abstract][Full Text] [Related]
16. Sympathetic nervous system in salt-sensitive and obese hypertension: amelioration of multiple abnormalities by a central sympatholytic agent.
Ernsberger P; Koletsky RJ; Collins LA; Bedol D
Cardiovasc Drugs Ther; 1996 Jun; 10 Suppl 1():275-82. PubMed ID: 8827950
[TBL] [Abstract][Full Text] [Related]
17. Leptin regulation of Agrp and Npy mRNA in the rat hypothalamus.
Korner J; Savontaus E; Chua SC; Leibel RL; Wardlaw SL
J Neuroendocrinol; 2001 Nov; 13(11):959-66. PubMed ID: 11737554
[TBL] [Abstract][Full Text] [Related]
18. AAV-mediated leptin receptor installation improves energy balance and the reproductive status of obese female Koletsky rats.
Keen-Rhinehart E; Kalra SP; Kalra PS
Peptides; 2005 Dec; 26(12):2567-78. PubMed ID: 16024137
[TBL] [Abstract][Full Text] [Related]
19. Localization of leptin receptor immunoreactivity in the lean and obese Zucker rat brain.
Yarnell DO; Knight DS; Hamilton K; Tulp O; Tso P
Brain Res; 1998 Feb; 785(1):80-90. PubMed ID: 9526052
[TBL] [Abstract][Full Text] [Related]
20. Decreased transport of leptin across the blood-brain barrier in rats lacking the short form of the leptin receptor.
Kastin AJ; Pan W; Maness LM; Koletsky RJ; Ernsberger P
Peptides; 1999 Dec; 20(12):1449-53. PubMed ID: 10698121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
